Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.56 extracted from

  • Shen, Y.; Joachimiak, A.; Rosner, M.R.; Tang, W.J.
    Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism (2006), Nature, 443, 870-874.
    View publication on PubMedView publication on EuropePMC

Crystallization (Commentary)

Crystallization (Comment) Organism
mutant E111Q in complex with substrates insulin B-chain, amyloid beta-protein, amylin and glucagon. Enzyme forms an enclosed cage just large enough to encapsulate insulin. enclosed substrate undergoes conformational changes to form beta-sheets with two discrete regions of enzyme for degradation Homo sapiens

Protein Variants

Protein Variants Comment Organism
D426C/K899C 30-40fold increase in activity compared to wild-type Homo sapiens
E111Q crystallization data Homo sapiens
N184C/Q828C 30-40fold increase in activity compared to wild-type Homo sapiens
S132C/E817C 30-40fold increase in activity compared to wild-type Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
amylin + H2O
-
Homo sapiens ?
-
?
amyloid beta-protein + H2O
-
Homo sapiens ?
-
?
Glucagon + H2O
-
Homo sapiens ?
-
?
Insulin B-chain + H2O
-
Homo sapiens ?
-
?